PD-1 and PDL-1 Inhibitor Market: Global Market Research Report and Industry Analysis
The PD-1 and PDL-1 inhibitor market represents one of the most transformative segments within the global oncology therapeutics landscape. Programmed cell death protein 1 and its ligand PDL-1 are immune checkpoint pathways that cancer cells exploit to evade immune system detection. PD-1 and PDL-1 inhibitors work by blocking these pathways, enabling the immune system to recognize and destroy...
0 Comments 0 Shares 104 Views 0 Reviews
Sponsored